All Comments by Dennis Selkoe
- CMS Plans to Limit Aduhelm Coverage to Clinical Trials
- Does More Aβ38 Mean Less Cognitive Decline in Alzheimer’s?
- Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat.
- Double Whammy: APP Uppsala Deletion Ups Aβ and Its Aggregation Propensity
- A New Era of Alzheimer’s Treatment
- FDA Advisory Committee Throws Cold Water on Aducanumab Filing
- Peter Davies, Beloved Giant of Alzheimer’s Disease Research, Dies at 72
- γ-Secretase Spotted Traveling Solo or in Pairs, Not in Big Groups
- Attack of the Clones? Memory CD8+ T Cells Stalk the AD, PD Brain
- Biogen/Eisai Halt Phase 3 Aducanumab Trials
- Could the Purported Muscle Exercise Hormone, Irisin, Jog Memory?
- CryoEM γ-Secretase Structures Nail APP, Notch Binding
- When Neurons Get Excited, They Spill α-Synuclein
- Robert D. Terry, 93, Co-Founder of U.S. Alzheimer’s Research
- Fatty Acid Greases the Wheels for α-Synuclein Multimers